1. Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer. Issue 1 (2021) Authors: Guo, Matthew Z; Marrone, Kristen A; Spira, Alexander; Freeman, Kristine; Scott, Susan C Journal: Touch reviews in oncology & haematology Issue: Volume 17:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗